Articles

Prof. Martine Piccart grew up in a house where medicine was part of the air. Her father, a gynecologist, treated patients at home. “I admired him deeply,” she says. “He helped people. I saw that up close. It left a…

CancerWorld had the opportunity to interview Nikos Papandreou, Member of the European Parliament and a dedicated advocate for cancer policy reform. With a background in politics, economics, and healthcare policy, Mr. Papandreou has been at the forefront of tackling Europe’s…

"One must imagine Sisyphus happy" Albert Camus Why me? This is probably the present-day question of every patient with cancer!  One of the consequences of our chaotic reality is cancer, which belongs to that class of diseases that impacts the…

What does it take to change the odds in cancer care? Innovation? Yes. But also: persistence. Collaboration. The refusal to accept that some lives matter less because of where they’re born. In this issue of CancerWorld, we focus not just…

I grew up around a lot of physicians,” begins Adrian Gottschalk, President and CEO of Foghorn Therapeutics, a biotech company redefining how we understand and treat complex diseases by targeting the chromatin regulatory system. “My late father was a professor…

The disparity in childhood cancer outcomes is one of the world’s most pressing health inequities. While over 80% of children with cancer are cured in high-income countries (HICs), survival drops to less than 30% in low- and middle-income countries (LMICs).…

Every year, the Sjöberg Prize, established by the Royal Swedish Academy of Sciences, honors researchers whose scientific discoveries in oncology are reshaping the understanding and treatment of cancer. The award stands alongside the most prestigious accolades in science, not only…

“I wanted to be a scientist when I grew up.” Boston. The city where old bricks and new ideas stand side by side. Where science, education, and innovation breathe together. The wind cuts through the streets of New England, sharp…

It’s long been clear that, in most patients with metastatic HER-positive breast cancer, adding effective HER2 blockade to cytotoxics can result in very prolonged responses. Janet Fricker reports on the prospective trials building evidence on whether – and in whom…

The two largest cities in Türkiye have stepped in to promote HPV vaccination at a local level, including free inoculation for young people from the poorest families, as the state fails to deliver on its commitment to add HPV to…